Adams Diversified Equity Fund’s Heron Therapeutics HRTX Stock Holding History

Adams Diversified Equity Fund’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15,500	Closed	-$402K	–	233
2018 Q4	$402K	Sell	15,500 -700	-4%	-$19.2K	0.02%	189
2018 Q3	$513K	Sell	16,200 -1,100	-6%	-$41K	0.03%	193
2018 Q2	$672K	Sell	17,300 -9,000	-34%	-$287K	0.04%	166
2018 Q1	$726K	Buy	+26,300	New	+$597K	0.04%	152

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Adams Diversified Equity Fund's HRTX Position: Q1 2019 in Review

Adams Diversified Equity Fund sold out of Heron Therapeutics (HRTX) in Q1 2019, closing a stake of 15,500 shares — an estimated $402K sold.

Adams Diversified Equity Fund first reported a position in HRTX in Q1 2018 and held it in 4 quarters. The position peaked at $726K in Q1 2018. 198 funds tracked by Wall St. Rank hold HRTX as of Q1 2019.

Adams Diversified Equity Fund reported no remaining Heron Therapeutics position as of Q1 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 15,500 Heron Therapeutics shares in Q1 2019, an estimated $402K.
Adams Diversified Equity Fund first reported a position in Heron Therapeutics in Q1 2018 and held it in 4 quarters.
Adams Diversified Equity Fund's Heron Therapeutics position peaked at $726K in Q1 2018.
198 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2019, filed 26 Apr 2019.